Commonly used antibiotic shows promise for combating Zika infections

NIH preclinical study suggests FDA-approved tetracycline-based antibiotics may slow infection and reduce neurological problems.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news